Document ID: chunk:federal_register_of_legislation:C2025C00060:section:10:p22
Version: federal_register_of_legislation:C2025C00060
Segment Type: section
Provision Reference: s 10 (pt 22/23)
Character Range: 1180434–1183236

is a risk that the substance will be used to unlawfully manufacture a controlled drug (other than a determined controlled drug).

301.9  Meaning of drug analogue
 (1) A substance is a drug analogue of a listed controlled drug, or a listed border controlled drug, if the substance is any of the following in relation to the listed drug (or in relation to a primary analogue of the listed drug), however the substance is obtained:
 (a) one of the following (a primary analogue):
 (i) a stereoisomer;
 (ii) a structural isomer having the same constituent groups;
 (iii) an alkaloid;
 (c) a structural modification obtained in one or more of the following ways:
 (i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;
 (ii) by the addition of hydrogen atoms to one or more unsaturated bonds;
 (iii) by the replacement of one or more of the groups or atoms specified in subsection (2) with one or more of the other groups or atoms specified in that subsection;
 (iv) by the conversion of a carboxyl or an ester group into an amide group;
 (d) any other homologue, analogue, chemical derivative or substance substantially similar in chemical structure.
Note: Some substances are taken, for the purposes of this Part, to be drug analogues only in relation to particular offences against this Part, or particular elements of those offences: see subsection 301.4(3).
 (2) The following groups and atoms are specified:
 (a) alkoxy, cyclic diether, acyl, acyloxy, mono‑amino or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;
 (b) alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;
 (c) halogen, hydroxy, nitro or amino groups;
 (d) hydrogen atoms.
 (3) However:
 (a) a drug analogue of a listed controlled drug does not include a substance that is itself a listed controlled drug; and
 (b) a drug analogue of a listed border controlled drug does not include a substance that is itself a listed border controlled drug.
 (4) In this section:
addition has its ordinary meaning.
replacement has its ordinary meaning.

Subdivision B—Serious drugs and precursors: commercial, marketable and trafficable quantities

301.10  Meaning of commercial quantity
  For the purposes of this Part, a commercial quantity of a serious drug, controlled precursor or border controlled precursor is a quantity not less than that provided by the following table:

Commercial quantities of serious drugs and precursors
Item                                                   Serious drug or precursor                                                                         Commercial quantity (minimum)